| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 2 |
| 1 | ACETAMINOPHEN 500MG | 2 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 3 | ADALIMUMAB | 2 |
| 4 | AZATHIOPRINE | 2 |
| 5 | BRENTUXIMAB VEDOTIN | 2 |
| 6 | CALCIUM GLUCONATE | 2 |
| 7 | CARBOPLATIN | 2 |
| 8 | DEXAMETHASONE SODIUM PHOSPHATE | 2 |
| 9 | ETOPOSIDE PHOSPHATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 1 | PATISIRAN | 2 | 0.0007 |
| 2 | MESNA INJECTION | 2 | 0.0002 |
| 3 | MESNA | 2 | 0.0002 |
| 4 | DEXAMETHASONE SODIUM PHOSPHATE | 2 | 0.0002 |
| 5 | BRENTUXIMAB VEDOTIN | 2 | 0.0002 |
| 6 | CALCIUM GLUCONATE | 2 | 0.0002 |
| 7 | PROMETHAZINE HYDROCHLORIDE | 2 | 0.0001 |
| 8 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| 9 | TEDUGLUTIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 3 |
| 1 | Platinum-based Drug [EPC] | 3 |
| 2 | CD30-directed Immunoconjugate [EPC] | 2 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 4 | Purine Antimetabolite [EPC] | 2 |
| 5 | Amide Local Anesthetic [EPC] | 1 |
| 6 | Antiarrhythmic [EPC] | 1 |
| 7 | Complement Inhibitor [EPC] | 1 |
| 8 | GLP-2 Analog [EPC] | 1 |
| 9 | Microtubule Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 1 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 2 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 3 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 5 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 7 | Antiarrhythmic [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |